 Ashley Nassiri
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 23 | 2025 | 88 | 9.570 |
Why?
| | Cochlear Implants | 21 | 2025 | 105 | 8.010 |
Why?
| | Speech Perception | 11 | 2024 | 83 | 5.330 |
Why?
| | Neuroma, Acoustic | 16 | 2024 | 41 | 4.100 |
Why?
| | Hearing Loss, Sensorineural | 9 | 2023 | 56 | 3.920 |
Why?
| | Stapes Surgery | 5 | 2023 | 14 | 2.310 |
Why?
| | Hearing | 5 | 2022 | 135 | 1.940 |
Why?
| | Deafness | 4 | 2022 | 80 | 1.720 |
Why?
| | Otolaryngology | 4 | 2025 | 86 | 1.550 |
Why?
| | Hearing Loss | 4 | 2022 | 210 | 1.410 |
Why?
| | Treatment Outcome | 16 | 2024 | 10230 | 1.190 |
Why?
| | Endoscopy | 4 | 2020 | 285 | 1.190 |
Why?
| | Radiosurgery | 4 | 2024 | 321 | 1.110 |
Why?
| | Patient Satisfaction | 3 | 2022 | 634 | 1.100 |
Why?
| | Facial Nerve | 5 | 2023 | 33 | 0.980 |
Why?
| | Mastoidectomy | 1 | 2024 | 1 | 0.930 |
Why?
| | Cholesteatoma, Middle Ear | 1 | 2024 | 3 | 0.930 |
Why?
| | Ear Canal | 1 | 2024 | 15 | 0.920 |
Why?
| | Hearing Loss, Conductive | 2 | 2021 | 25 | 0.880 |
Why?
| | Cholesteatoma | 1 | 2023 | 11 | 0.850 |
Why?
| | Retrospective Studies | 25 | 2025 | 14518 | 0.800 |
Why?
| | Stapedius | 2 | 2022 | 3 | 0.790 |
Why?
| | Otosclerosis | 2 | 2019 | 5 | 0.790 |
Why?
| | Hearing Loss, Central | 2 | 2019 | 5 | 0.770 |
Why?
| | Telemedicine | 4 | 2022 | 788 | 0.750 |
Why?
| | Tendons | 2 | 2023 | 106 | 0.720 |
Why?
| | Value-Based Purchasing | 1 | 2020 | 7 | 0.680 |
Why?
| | Surgical Equipment | 1 | 2020 | 13 | 0.680 |
Why?
| | Nasal Surgical Procedures | 1 | 2020 | 6 | 0.670 |
Why?
| | Nasal Obstruction | 1 | 2020 | 27 | 0.660 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 201 | 0.630 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2019 | 21 | 0.630 |
Why?
| | Gingival Neoplasms | 1 | 2019 | 10 | 0.620 |
Why?
| | Labyrinthitis | 1 | 2018 | 2 | 0.620 |
Why?
| | Mandibular Neoplasms | 1 | 2019 | 22 | 0.620 |
Why?
| | Humans | 58 | 2025 | 129650 | 0.610 |
Why?
| | Otologic Surgical Procedures | 1 | 2018 | 18 | 0.600 |
Why?
| | Health Services Accessibility | 2 | 2025 | 902 | 0.600 |
Why?
| | Evoked Potentials, Auditory | 1 | 2019 | 179 | 0.590 |
Why?
| | Adult | 22 | 2024 | 35576 | 0.570 |
Why?
| | Reoperation | 2 | 2020 | 545 | 0.550 |
Why?
| | Neurilemmoma | 3 | 2024 | 23 | 0.480 |
Why?
| | Postoperative Period | 4 | 2020 | 329 | 0.480 |
Why?
| | Postoperative Complications | 5 | 2023 | 2483 | 0.450 |
Why?
| | Ear, Inner | 2 | 2024 | 45 | 0.450 |
Why?
| | Bone Conduction | 3 | 2023 | 31 | 0.440 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2019 | 626 | 0.430 |
Why?
| | Decision Making | 1 | 2020 | 851 | 0.410 |
Why?
| | Hearing Loss, Bilateral | 2 | 2023 | 12 | 0.400 |
Why?
| | Incidence | 4 | 2023 | 2644 | 0.390 |
Why?
| | Microsurgery | 3 | 2022 | 70 | 0.390 |
Why?
| | Male | 19 | 2024 | 63681 | 0.370 |
Why?
| | Tinnitus | 2 | 2022 | 57 | 0.360 |
Why?
| | Aged | 12 | 2024 | 22103 | 0.350 |
Why?
| | Female | 18 | 2024 | 68776 | 0.340 |
Why?
| | Middle Aged | 14 | 2024 | 31154 | 0.340 |
Why?
| | Surgeons | 2 | 2025 | 261 | 0.320 |
Why?
| | Hearing Aids | 2 | 2022 | 74 | 0.320 |
Why?
| | Preoperative Period | 2 | 2020 | 115 | 0.320 |
Why?
| | Ear Neoplasms | 2 | 2024 | 8 | 0.290 |
Why?
| | Prospective Studies | 5 | 2023 | 7133 | 0.290 |
Why?
| | United States | 8 | 2025 | 13903 | 0.290 |
Why?
| | Incus | 2 | 2023 | 8 | 0.240 |
Why?
| | Stapes | 2 | 2023 | 32 | 0.240 |
Why?
| | Mastoid | 1 | 2024 | 16 | 0.230 |
Why?
| | Child | 7 | 2023 | 20883 | 0.220 |
Why?
| | Facial Paralysis | 1 | 2023 | 17 | 0.220 |
Why?
| | Child, Preschool | 4 | 2023 | 10517 | 0.200 |
Why?
| | Artifacts | 1 | 2023 | 126 | 0.200 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2022 | 7 | 0.200 |
Why?
| | Neoplasms, Connective Tissue | 1 | 2022 | 3 | 0.200 |
Why?
| | Mesenchymoma | 1 | 2022 | 7 | 0.200 |
Why?
| | Osteomalacia | 1 | 2022 | 5 | 0.200 |
Why?
| | Paraneoplastic Syndromes | 1 | 2022 | 11 | 0.200 |
Why?
| | Cadaver | 1 | 2023 | 306 | 0.190 |
Why?
| | Hemangioma, Capillary | 1 | 2021 | 13 | 0.190 |
Why?
| | Prolapse | 1 | 2021 | 5 | 0.190 |
Why?
| | Facial Nerve Diseases | 1 | 2021 | 4 | 0.190 |
Why?
| | Nutrition Surveys | 1 | 2023 | 260 | 0.190 |
Why?
| | Meningioma | 1 | 2022 | 82 | 0.180 |
Why?
| | Intraoperative Period | 1 | 2021 | 53 | 0.180 |
Why?
| | Cartilage Diseases | 1 | 2022 | 39 | 0.180 |
Why?
| | Meningeal Neoplasms | 1 | 2022 | 93 | 0.180 |
Why?
| | Tertiary Care Centers | 1 | 2022 | 151 | 0.180 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2021 | 100 | 0.180 |
Why?
| | Aged, 80 and over | 4 | 2022 | 7086 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 5 | 2023 | 3408 | 0.180 |
Why?
| | Travel | 1 | 2022 | 122 | 0.180 |
Why?
| | Paraganglioma | 1 | 2021 | 49 | 0.180 |
Why?
| | Young Adult | 4 | 2022 | 12426 | 0.170 |
Why?
| | Benchmarking | 1 | 2022 | 176 | 0.170 |
Why?
| | Appointments and Schedules | 1 | 2020 | 84 | 0.160 |
Why?
| | Ear Ossicles | 1 | 2019 | 15 | 0.160 |
Why?
| | Audiometry | 1 | 2019 | 27 | 0.150 |
Why?
| | Patient Advocacy | 1 | 2019 | 73 | 0.150 |
Why?
| | Feedback | 1 | 2019 | 162 | 0.150 |
Why?
| | Rural Population | 1 | 2022 | 518 | 0.140 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2535 | 0.140 |
Why?
| | Temporal Bone | 3 | 2022 | 49 | 0.140 |
Why?
| | Disease-Free Survival | 1 | 2019 | 648 | 0.140 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 485 | 0.140 |
Why?
| | Tumor Burden | 3 | 2022 | 286 | 0.140 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5066 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 373 | 0.130 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1295 | 0.120 |
Why?
| | Infant | 2 | 2018 | 9024 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2020 | 505 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2020 | 732 | 0.110 |
Why?
| | Adolescent | 4 | 2022 | 20393 | 0.110 |
Why?
| | Survival Rate | 1 | 2019 | 1877 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2022 | 825 | 0.110 |
Why?
| | Communication | 1 | 2019 | 846 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2020 | 894 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1171 | 0.100 |
Why?
| | Cochlea | 2 | 2023 | 100 | 0.090 |
Why?
| | Neurosurgical Procedures | 2 | 2023 | 173 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1266 | 0.080 |
Why?
| | Pandemics | 3 | 2022 | 1488 | 0.080 |
Why?
| | Hearing Tests | 2 | 2019 | 47 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2441 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5406 | 0.070 |
Why?
| | Pain | 2 | 2022 | 789 | 0.060 |
Why?
| | Quality of Life | 3 | 2022 | 2704 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3083 | 0.060 |
Why?
| | Skull Base | 1 | 2023 | 45 | 0.050 |
Why?
| | Dissection | 1 | 2023 | 51 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 204 | 0.050 |
Why?
| | Neoplasm Regression, Spontaneous | 1 | 2022 | 3 | 0.050 |
Why?
| | Petrous Bone | 1 | 2022 | 6 | 0.050 |
Why?
| | Head | 1 | 2023 | 96 | 0.050 |
Why?
| | Audiometry, Evoked Response | 1 | 2022 | 11 | 0.050 |
Why?
| | Auditory Threshold | 1 | 2022 | 39 | 0.050 |
Why?
| | Cochlear Nerve | 1 | 2022 | 8 | 0.050 |
Why?
| | Tertiary Healthcare | 1 | 2022 | 29 | 0.050 |
Why?
| | Electrodes, Implanted | 1 | 2023 | 107 | 0.050 |
Why?
| | Ear Cartilage | 1 | 2022 | 3 | 0.050 |
Why?
| | Magnets | 1 | 2022 | 19 | 0.050 |
Why?
| | Literacy | 1 | 2022 | 10 | 0.050 |
Why?
| | Face | 1 | 2023 | 165 | 0.050 |
Why?
| | Chorda Tympani Nerve | 1 | 2021 | 12 | 0.050 |
Why?
| | Ear, External | 1 | 2022 | 24 | 0.050 |
Why?
| | Scalp | 1 | 2022 | 34 | 0.050 |
Why?
| | Craniotomy | 1 | 2022 | 69 | 0.050 |
Why?
| | Round Window, Ear | 1 | 2021 | 16 | 0.050 |
Why?
| | Reflex | 1 | 2022 | 65 | 0.050 |
Why?
| | Ligaments | 1 | 2021 | 54 | 0.050 |
Why?
| | Cranial Nerves | 1 | 2020 | 12 | 0.040 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 47 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5420 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2023 | 1201 | 0.040 |
Why?
| | Cholesterol | 1 | 2022 | 412 | 0.040 |
Why?
| | Prosthesis Failure | 1 | 2020 | 114 | 0.040 |
Why?
| | Medicare | 1 | 2022 | 720 | 0.030 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 544 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 964 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2635 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2717 | 0.030 |
Why?
| | Registries | 1 | 2021 | 1896 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4897 | 0.030 |
Why?
| | Time Factors | 1 | 2022 | 6556 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1717 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2736 | 0.020 |
Why?
|
|
Nassiri's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|